3 Of The Best Turnaround Stocks: AstraZeneca plc, Debenhams Plc And Imagination Technologies Group plc

These 3 stocks could be stunning long-term buys: AstraZeneca plc (LON: AZN), Debenhams Plc (LON: DEB) and Imagination Technologies Group plc (LON: IMG).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In recent years, Debenhams (LSE: DEB) has struggled to come to terms with a changing UK consumer landscape. With household budgets having come under sustained pressure from wage growth that has consistently fallen behind inflation, consumers have become increasingly price conscious and have traded down to lower-priced options. As such, mid-tier operators such as Debenhams have seen their sales and profitability come under pressure.

In response, Debenhams offered greater discounts and while this aided sales growth, it came at the expense of margins. As a result, its bottom line declined and this hurt investor sentiment.

Now though, Debenhams has a new strategy focused on margins and it’s having a positive impact on the company’s bottom line. Last year Debenhams posted a rise in net profit of 3%, while further positive growth is forecast for this year and next. With the shares trading on a price-to-earnings (P/E) ratio of just 10.4, there’s significant upward rerating potential on the cards. And increasing household budgets (in real terms) are likely to provide Debenhams with a tailwind moving forward.

Potential in the pipeline

Also offering stunning turnaround prospects is pharmaceuticals company AstraZeneca (LSE: AZN). Like Debenhams, it has endured a difficult period, with the company’s pipeline of new drugs failing to fully offset the loss of patents on key blockbuster drugs. Due to this, AstraZeneca’s bottom line has posted a sustained fall in recent years, with this trend likely to continue in the near term.

However, after multiple major acquisitions, AstraZeneca’s drug pipeline now offers huge long-term appeal. Evidence of this can be seen in the bid rumours for the company that have persisted in the last couple of years. Although a bid would equate to a high short-term gain in the company’s share price, AstraZeneca’s drug pipeline has the potential to deliver even higher returns in the long run. And with its shares trading on a P/E ratio of 14.9, they seem to offer good value for money given their turnaround potential.

Big change ahead

Meanwhile, Imagination Technologies (LSE: IMG) is another company with huge turnaround potential. Clearly, it remains a relatively high-risk play as it’s now expected to post a loss for the current financial year. Furthermore, there are major changes ongoing at the company following its profit warning and they equate to great uncertainty regarding Imagination Technologies’ future prospects.

Notably, the company is searching for a new CEO and he/she is likely to bring a revised strategy that could impact on investor sentiment in the short run. And with it being in the process of a major restructuring that includes asset disposals, Imagination Technologies could be a very different company with a vastly changed business model in a year or two’s time.

But with a return to profit forecast for next year and a price-to-earnings growth (PEG) ratio of 0.8, it may be worth buying for less risk-averse investors.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca and Debenhams. The Motley Fool UK owns shares of Imagination Technologies. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »